Xiangrong Cui

1.0k total citations
43 papers, 745 citations indexed

About

Xiangrong Cui is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Xiangrong Cui has authored 43 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Xiangrong Cui's work include Reproductive Biology and Fertility (9 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Xiangrong Cui is often cited by papers focused on Reproductive Biology and Fertility (9 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Xiangrong Cui collaborates with scholars based in China, United States and United Kingdom. Xiangrong Cui's co-authors include Xuan Jing, Hongping Liang, Chonghua Hao, Jing Zhu, Xueqing Wu, Xueqing Wu, Chunlan Long, Jie Tian, Zhenqiang Wang and Xiaojuan Yang and has published in prestigious journals such as PLoS ONE, Clinica Chimica Acta and American Journal of Physiology-Renal Physiology.

In The Last Decade

Xiangrong Cui

38 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangrong Cui China 16 383 196 169 126 125 43 745
Zhiming Cai China 16 426 1.1× 215 1.1× 89 0.5× 108 0.9× 64 0.5× 28 680
Maciej Brązert Poland 15 285 0.7× 108 0.6× 124 0.7× 142 1.1× 150 1.2× 43 594
Aki Isobe Japan 15 244 0.6× 175 0.9× 177 1.0× 166 1.3× 60 0.5× 25 800
Songshu Xiao China 18 280 0.7× 122 0.6× 122 0.7× 124 1.0× 171 1.4× 46 810
Masayuki Futagami Japan 16 405 1.1× 156 0.8× 304 1.8× 226 1.8× 47 0.4× 62 957
Anita Chudecka-Głaz Poland 17 227 0.6× 155 0.8× 375 2.2× 232 1.8× 123 1.0× 85 863
Aytekin Akyol Türkiye 14 464 1.2× 151 0.8× 188 1.1× 313 2.5× 54 0.4× 40 964
Synnöve Staff Finland 20 454 1.2× 172 0.9× 264 1.6× 429 3.4× 122 1.0× 48 1.2k
Seema Parte United States 17 561 1.5× 115 0.6× 127 0.8× 214 1.7× 291 2.3× 26 840
Akiko Tanabe Japan 16 305 0.8× 155 0.8× 261 1.5× 250 2.0× 53 0.4× 24 764

Countries citing papers authored by Xiangrong Cui

Since Specialization
Citations

This map shows the geographic impact of Xiangrong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangrong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangrong Cui more than expected).

Fields of papers citing papers by Xiangrong Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangrong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangrong Cui. The network helps show where Xiangrong Cui may publish in the future.

Co-authorship network of co-authors of Xiangrong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangrong Cui. A scholar is included among the top collaborators of Xiangrong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangrong Cui. Xiangrong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhu, Xinyu, Robert J. Ju, Shu Wang, et al.. (2025). Mechanisms and treatment modalities related to premature ovarian insufficiency in mitochondria: literature review. Journal of Ovarian Research. 19(1). 11–11.
4.
Jing, Xuan, Sufen Li, Zhiping Zhang, et al.. (2024). Classic congenital adrenal hyperplasia with unilateral functional adrenal cortical adenoma: case report. Gynecological Endocrinology. 40(1). 2373741–2373741.
5.
Huang, Xia, et al.. (2024). Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis. Perfusion. 40(5). 1088–1102. 3 indexed citations
6.
Cui, Xiangrong, et al.. (2024). Stem cell-based therapeutic potential in female ovarian aging and infertility. Journal of Ovarian Research. 17(1). 171–171. 9 indexed citations
7.
Li, Lu, Xiangrong Cui, Jian Yang, Xueqing Wu, & Gang Zhao. (2023). Using feature optimization and LightGBM algorithm to predict the clinical pregnancy outcomes after in vitro fertilization. Frontiers in Endocrinology. 14. 1305473–1305473. 8 indexed citations
8.
9.
Cui, Xiangrong, et al.. (2022). Genetic of preimplantation diagnosis of dysmorphic facial features and intellectual developmental disorder (CHDFIDD) without congenital heart defects. Molecular Genetics & Genomic Medicine. 10(2). e1863–e1863. 1 indexed citations
10.
Cui, Xiangrong, et al.. (2021). Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling. Journal of Ovarian Research. 14(1). 71–71. 9 indexed citations
11.
Cui, Xiangrong, Xueqing Wu, Qiang Li, & Xuan Jing. (2020). Mutations of the cystic fibrosis transmembrane conductance regulator gene in males with congenital bilateral absence of the vas deferens: Reproductive implications and genetic counseling (Review). Molecular Medicine Reports. 22(5). 3587–3596. 10 indexed citations
12.
Cui, Xiangrong, Xuan Jing, Xueqing Wu, et al.. (2020). <p>Analyses of DNA Methylation Involved in the Activation of Nuclear Karyopherin Alpha 2 Leading to Identify the Progression and Prognostic Significance Across Human Breast Cancer</p>. Cancer Management and Research. Volume 12. 6665–6677. 8 indexed citations
13.
Cui, Xiangrong, Hongping Liang, Chonghua Hao, & Xuan Jing. (2020). <p>Homer1 is a Potential Biomarker for Prognosis in Human Colorectal Carcinoma, Possibly in Association with G3BP1 Signaling</p>. Cancer Management and Research. Volume 12. 2899–2909. 7 indexed citations
14.
Jing, Xuan, Hongping Liang, Chonghua Hao, Hongxia Li, & Xiangrong Cui. (2019). Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer. Aging. 11(18). 7442–7456. 11 indexed citations
15.
Jing, Xuan, et al.. (2018). Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis. Oncology Letters. 16(3). 3092–3100. 6 indexed citations
16.
Cui, Xiangrong, Chunlan Long, Jing Zhu, & Jie Tian. (2017). Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR. Cellular Physiology and Biochemistry. 41(2). 598–608. 30 indexed citations
17.
Cui, Xiangrong, Xuan Jing, Chunlan Long, Jie Tian, & Jing Zhu. (2017). Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis. Oncotarget. 8(12). 19049–19056. 31 indexed citations
18.
Jing, Xuan, et al.. (2017). Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis. Clinica Chimica Acta. 468. 159–165. 20 indexed citations
19.
Cui, Xiangrong, Xuan Jing, Xueqing Wu, et al.. (2016). DNA methylation in spermatogenesis and male infertility. Experimental and Therapeutic Medicine. 12(4). 1973–1979. 66 indexed citations
20.
Cui, Xiangrong, Xuan Jing, Xueqing Wu, Zhenqiang Wang, & Qiang Li. (2016). Potential effect of smoking on semen quality through DNA damage and the downregulation of Chk1 in sperm. Molecular Medicine Reports. 14(1). 753–761. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026